Purpose We aimed to develop and validate a simplified, novel quantification method for
radioiodine whole-body scans (WBSs) as a predictor for the treatment response in …

Differentiated thyroid cancer (DTC) is the most common endocrine malignancy with a
growing incidence worldwide. The initial conventional management is surgery, followed by …

Elsewhere in this volume, authorities have described general aspects of the diagnosis and
management of differentiated thyroid carcinoma (DTC) with recommendations largely …

Aim To study the clinical yield of diagnostic whole body 131 I scintigraphy (DxWBS) in the
follow-up of differentiated thyroid carcinoma (DTC) patients in relation to stimulated …

Introduction DTC patients having detectable Tg and negative post-therapeutic 131 I-WBS
have to be investigated by different imaging techniques to detect metastases. Purpose …

Context: American Thyroid Association and European Thyroid Association guidelines
cannot recommend for or against radioactive iodine (RAI) ablation after surgery in low-risk …

This review of radioactive iodide treatment (RAIT) extends from historical origins to its
modern utilization in differentiated thyroid cancer (DTC). The principles embedded in the …

Background: At present, empirical radioactive iodine therapy is recommended for patients
with thyroid cancer and elevated thyroglobulin (Tg) after initial therapy when neck …

Objective Surgery and radioactive iodine (RAI) ablation constitute the mainstay of the
treatment of differentiated thyroid carcinoma (DTC). In this study, we aimed to evaluate the …

Purpose The optimal preablative level of thyrotropin (TSH) for patients with differentiated
thyroid cancer (DTC) to achieve better response after 131 I ablation remains unknown. The …